ARCHIVES

NCI Offers Informations, Resources, To Industry.

This article is from The Cancer Letter archive.

Vol. 27 No. 14 | April 6, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Guest Editorial: The Supreme Court Decision on the ACA and What It Can Mean to Oncology

June 29, 2012

Porter Softens Proposal To require SBIR Scores To Match R01s

July 26, 1996

House DoD Report Provides $15 Million For Lung Cancer Screening

October 23, 2009

Implantable Drug Delivery Device Offers Better Pain Relief

September 27, 2002